• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉注射与静脉注射氯胺酮的急性抗抑郁作用

Acute antidepressant effects of intramuscular versus intravenous ketamine.

作者信息

Chilukuri Harihar, Reddy Narasimha Pothula, Pathapati Ram Mohan, Manu Arkalgud Nagesha, Jollu Sharada, Shaik Ahammed Basha

机构信息

Department of Psychiatry, Malla Reddy Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India.

Department of Anaesthesia, Narayana Medical College, Nellore, Andhra Pradesh, India.

出版信息

Indian J Psychol Med. 2014 Jan;36(1):71-6. doi: 10.4103/0253-7176.127258.

DOI:10.4103/0253-7176.127258
PMID:24701015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3959024/
Abstract

OBJECTIVE

Conventional antidepressants take two weeks before their therapeutic action begins. Recent studies have reported on the rapid antidepressant effect of ketamine when given as an intravenous (I.V.) infusion. Little is known about its intramuscular (I.M.) use in depression. Hence this study was conducted to compare the safety, tolerability and efficacy of I.M. versus. I.V. ketamine in Major Depression (ICD-10).

MATERIALS AND METHODS

It was a randomized open label parallel group study in a tertiary care teaching hospital. Study sample consisted of 27 subjects having major depression divided randomly into three groups of nine subjects each. Ketamine administered to each group in the dose of 0.5 mg/kg as an I.V. infusion, as 0.5 mg/kg I.M. or 0.25 mg/kg I.M. respectively. Depression rated on the Hamilton Depression Rating Scale (HAM-D) before the injection, two hours later, the next day, and after three days. Data analyzed using the Statistical Package for Social Sciences (SPSS).

RESULTS

Mean age of the sample was 36.81 years (SD 11.815). Two hours after the injection, HAM-D fell by 58.86%, 60.29% & 57.36% in each group respectively. The improvement was sustained for next three days. Adverse effects noticed were rare, of mild nature and transient, lasting less than an hour.

CONCLUSIONS

Intramuscular ketamine in the dose of 0.25 mg/kg is as effective and safe as 0.5 mg/kg given either I.M. or I.V., substantially alleviating depressive symptoms within a few hours and sustained for 3 days.

摘要

目的

传统抗抑郁药在开始治疗作用前需要两周时间。最近的研究报道了静脉注射氯胺酮时的快速抗抑郁作用。关于其在抑郁症中的肌肉注射使用情况知之甚少。因此,本研究旨在比较肌肉注射与静脉注射氯胺酮在重度抑郁症(ICD - 10)中的安全性、耐受性和疗效。

材料与方法

这是一项在三级护理教学医院进行的随机开放标签平行组研究。研究样本包括27名重度抑郁症患者,随机分为三组,每组9名受试者。分别以0.5mg/kg的剂量对每组进行静脉输注、0.5mg/kg肌肉注射或0.25mg/kg肌肉注射氯胺酮。在注射前、两小时后、次日及三天后使用汉密尔顿抑郁量表(HAM - D)对抑郁程度进行评分。使用社会科学统计软件包(SPSS)进行数据分析。

结果

样本的平均年龄为36.81岁(标准差11.815)。注射两小时后,每组的HAM - D分别下降了58.86%、60.29%和57.36%。这种改善在接下来的三天内持续。观察到的不良反应很少,性质轻微且短暂,持续时间不到一小时。

结论

0.25mg/kg剂量的肌肉注射氯胺酮与0.5mg/kg肌肉注射或静脉注射的氯胺酮一样有效且安全,能在数小时内显著减轻抑郁症状,并持续三天。

相似文献

1
Acute antidepressant effects of intramuscular versus intravenous ketamine.肌肉注射与静脉注射氯胺酮的急性抗抑郁作用
Indian J Psychol Med. 2014 Jan;36(1):71-6. doi: 10.4103/0253-7176.127258.
2
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.重复静脉注射氯胺酮对单相和双相抑郁患者的快速和长期抗抑郁作用。
J Psychiatr Res. 2018 Nov;106:61-68. doi: 10.1016/j.jpsychires.2018.09.013. Epub 2018 Sep 25.
3
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.单次静脉注射氯胺酮增强新起始的艾司西酞普兰治疗重度抑郁症的疗效:一项随机、安慰剂对照的4周研究结果
Psychol Med. 2016 Feb;46(3):623-35. doi: 10.1017/S0033291715002159. Epub 2015 Oct 19.
4
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.一项关于N-甲基-D-天冬氨酸拮抗剂治疗难治性重度抑郁症的随机试验。
Arch Gen Psychiatry. 2006 Aug;63(8):856-64. doi: 10.1001/archpsyc.63.8.856.
5
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.重复静脉注射氯胺酮治疗难治性抑郁症的安全性和有效性。
Biol Psychiatry. 2010 Jan 15;67(2):139-45. doi: 10.1016/j.biopsych.2009.08.038.
6
Intramuscular ketamine in acute depression: A report on two cases.肌肉注射氯胺酮治疗急性抑郁症:两例报告。
Indian J Psychiatry. 2013 Apr;55(2):186-8. doi: 10.4103/0019-5545.111461.
7
Novel Augmentation Strategies in Major Depression.重度抑郁症的新型强化治疗策略
Dan Med J. 2017 Apr;64(4).
8
Rapid response with ketamine on suicidal cognition in resistant depression.氯胺酮对难治性抑郁症自杀认知的快速反应。
Indian J Psychol Med. 2012 Apr;34(2):170-5. doi: 10.4103/0253-7176.101793.
9
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.在治疗抵抗性重度抑郁症患者中,单次输注 N-甲基-D-天冬氨酸拮抗剂后,自杀意念迅速缓解。
J Clin Psychiatry. 2010 Dec;71(12):1605-11. doi: 10.4088/JCP.09m05327blu. Epub 2010 Jul 13.
10
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.静脉注射氯胺酮治疗青少年治疗抵抗性抑郁症的疗效:一项随机咪达唑仑对照试验。
Am J Psychiatry. 2021 Apr 1;178(4):352-362. doi: 10.1176/appi.ajp.2020.20010018. Epub 2021 Mar 3.

引用本文的文献

1
A systematic scoping review of Indian literature on ketamine use for treating psychiatric disorders.关于氯胺酮用于治疗精神疾病的印度文献的系统综述。
Ind Psychiatry J. 2025 May-Aug;34(2):167-178. doi: 10.4103/ipj.ipj_376_24. Epub 2025 May 22.
2
Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks.氯胺酮辅助康复(KARE):一项针对有甲基苯丙胺使用障碍和感染艾滋病毒风险的公共保险患者的氯胺酮辅助心理治疗开放标签试点试验方案。
BMJ Open. 2025 Aug 24;15(8):e100775. doi: 10.1136/bmjopen-2025-100775.
3
Clinical trials since 2020 of rapid anti-suicidal ideation effects of ketamine and its enantiomers: a systematic review.2020年以来氯胺酮及其对映体快速抗自杀意念作用的临床试验:一项系统评价
Transl Psychiatry. 2025 Feb 6;15(1):44. doi: 10.1038/s41398-025-03255-0.
4
"This is you teaching you:" Exploring providers' perspectives on experiential learning and enhancing patient safety and outcomes in ketamine-assisted therapy.“这是你在教你自己:”探索提供者对体验式学习的看法,以及如何在氯胺酮辅助治疗中增强患者的安全性和治疗效果。
PLoS One. 2024 Aug 29;19(8):e0306381. doi: 10.1371/journal.pone.0306381. eCollection 2024.
5
Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study.氯胺酮治疗难治性重度抑郁症:双盲活性对照交叉研究。
J Psychopharmacol. 2024 Feb;38(2):162-167. doi: 10.1177/02698811241227026. Epub 2024 Jan 31.
6
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.创伤后应激障碍治疗的迷幻未来。
Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147.
7
Research on treatment-related aspects of depression from India in the preceding decade (2014-2023): An updated systematic review.过去十年(2014 - 2023年)印度抑郁症治疗相关方面的研究:最新系统综述
Indian J Psychiatry. 2023 Nov;65(11):1112-1121. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_810_23. Epub 2023 Nov 24.
8
A Comparison of the Anti-Anxiety Effects of Oral Ketamine and Fluvoxamine in Children with Separation Anxiety Disorder Manifesting as School Refusal.口服氯胺酮与氟伏沙明对表现为学校拒学的分离焦虑症儿童抗焦虑作用的比较
Adv Biomed Res. 2023 Apr 27;12:110. doi: 10.4103/abr.abr_388_22. eCollection 2023.
9
Retrospective data analysis to determine the effectiveness of intravenous ketamine therapy on patients suffering from depression with suicidal ideation.进行回顾性数据分析,以确定静脉注射氯胺酮疗法对有自杀意念的抑郁症患者的疗效。
Ind Psychiatry J. 2023 Jan-Jun;32(1):86-92. doi: 10.4103/ipj.ipj_231_21. Epub 2022 Nov 10.
10
Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial.氯胺酮肌肉注射与艾司西酞普兰及阿立哌唑用于难治性抑郁症患者的急性和维持治疗:一项随机双盲临床试验
Front Psychiatry. 2022 Jul 22;13:830301. doi: 10.3389/fpsyt.2022.830301. eCollection 2022.

本文引用的文献

1
Intramuscular ketamine in acute depression: A report on two cases.肌肉注射氯胺酮治疗急性抑郁症:两例报告。
Indian J Psychiatry. 2013 Apr;55(2):186-8. doi: 10.4103/0019-5545.111461.
2
Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?氯胺酮带来的快速抗抑郁反应:它是难治性抑郁症的解决方案吗?
Indian J Psychol Med. 2012 Jan;34(1):56-60. doi: 10.4103/0253-7176.96161.
3
Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats.低剂量氯胺酮的抗抑郁样作用与雌性 Wistar-Kyoto 大鼠海马 AMPA/NMDA 受体密度比值增加有关。
Neuroscience. 2012 Jun 28;213:72-80. doi: 10.1016/j.neuroscience.2012.03.052. Epub 2012 Apr 19.
4
Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer.在患有晚期癌症的抑郁患者中,重复肌肉注射氯胺酮对情绪和疼痛的反应。
J Palliat Med. 2012 Apr;15(4):400-3. doi: 10.1089/jpm.2011.0314. Epub 2012 Apr 2.
5
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.静息状态下 NMDA 受体阻断可迅速引发抗抑郁行为反应。
Nature. 2011 Jun 15;475(7354):91-5. doi: 10.1038/nature10130.
6
Ketamine alleviates fear, depression, and suicidal ideation in terminally ill patients.氯胺酮可缓解晚期患者的恐惧、抑郁和自杀念头。
J Palliat Med. 2011 Apr;14(4):389. doi: 10.1089/jpm.2010.0499.
7
Attention deficit hyperactivity disorder and sleep. Insomnia and other sleep problems may worsen symptoms of ADHD; treatment options exist.注意力缺陷多动障碍与睡眠。失眠及其他睡眠问题可能会加重注意力缺陷多动障碍的症状;有相应的治疗选择。
Harv Ment Health Lett. 2010 Dec;27(6):6-7.
8
Topological traps control flow on real networks: the case of coordination failures.拓扑陷阱控制真实网络中的流:协调失败案例。
PLoS One. 2010 Dec 9;5(12):e15210. doi: 10.1371/journal.pone.0015210.
9
Cracking the moody brain: lifting the mood with ketamine.破解喜怒无常的大脑:用氯胺酮改善情绪。
Nat Med. 2010 Dec;16(12):1384-5. doi: 10.1038/nm1210-1384.
10
Innovative approaches to treatment - refractory depression: The ketamine story.难治性抑郁症的创新治疗方法:氯胺酮的故事。
Indian J Psychiatry. 2010 Apr;52(2):97-9. doi: 10.4103/0019-5545.64573.